V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10419025 | 10069145 | 0 | 71.55 | Disease modification (D) | 2019-09-05 | 2020-01-03 | ANAGRELIDE | 02 | N | CHLORAMBUCIL + ETOPOSIDE | 100296097 |
| 10419090 | 10069146 | 1.72 | 64 | null | 2020-01-12 | 2020-02-09 | null | 02 | null | OSIMERTINIB | 100035807 |
| 10419189 | 10069147 | 1.75 | 76.4 | null | 2020-10-09 | 2020-12-30 | VISMODEGIB | 02 | null | FCR | 101301716 |
| 10420614 | 10069150 | 1.5 | 77.1 | null | 2018-05-30 | 2018-06-07 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + MITOMYCIN | 101164902 |
| 10420763 | 10069152 | 1.68 | 54.75 | null | 2019-08-26 | 2019-09-23 | null | null | null | CAPECITABINE + MITOMYCIN | 100620821 |
| 10421926 | 10069156 | null | null | Palliative (P) | 2020-05-06 | 2020-05-27 | Obinutuzumab | 02 | N | IDELALISIB + RITUXIMAB | 101205507 |
| 10422194 | 10069157 | 1.76 | 96.45 | null | 2017-05-19 | 2017-05-20 | FLUOROURACIL + OXALIPLATIN | N | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100340854 |
| 10422305 | 10069158 | 1.84 | 71.6 | null | 2020-06-14 | 2021-02-08 | IVE | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100263951 |
| 10422449 | 10069159 | 1.69 | 83 | null | 2018-10-18 | 2019-07-31 | ABVD | N | null | OXALIPLATIN + RALTITREXED | 100484608 |
| 10422545 | 10069160 | 1.57 | 0 | Not known (9) | 2017-11-11 | 2018-01-04 | Nilotinib | 02 | N | BENDAMUSTINE + OBINUTUZUMAB | 101696199 |
| 10423209 | 10069162 | 1.69 | 80 | Curative (C) | null | 2020-12-20 | Irinotecan + Raltitrexed | 02 | N | CYTARABINE + ETOPOSIDE + LOMUSTINE + MELPHALAN | 100991386 |
| 10423408 | 10069165 | 1.7 | 91.6 | null | null | 2019-05-10 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101443785 |
| 10423604 | 10069166 | null | null | Curative (C) | 2022-04-03 | 2022-04-11 | LUTETIUM-177 | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100206028 |
| 10424062 | 10069168 | 1.57 | 77.5 | null | null | 2021-11-03 | Cyclophosphamide+Doce+Tras Main | 02 | N | METHOTREXATE + MITOMYCIN + MITOXANTRONE | 100890552 |
| 10425272 | 10069172 | 164 | 94.2 | null | 2017-12-22 | 2017-12-22 | CARFILZOMIB + Dexamethasone | 2 | null | CERITINIB | 100998880 |
| 10425742 | 10069173 | 1.61 | 99 | Curative (C) | 2019-05-21 | 2019-06-02 | CAV | 02 | N | BENDAMUSTINE + OBINUTUZUMAB | 101324934 |
| 10425811 | 10069174 | 1.59 | 53.15 | Curative (C) | null | 2022-02-13 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | null | CARFILZOMIB | 100147381 |
| 10426008 | 10069175 | 1.81 | 90.7 | null | 2018-07-21 | 2018-11-04 | DA 3+8 | 02 | null | IRINOTECAN + RALTITREXED | 100681031 |
| 10426029 | 10069176 | null | null | null | 2018-10-12 | 2019-01-19 | Irinotecan + Modified De Gramont | 99 | null | CYTARABINE | 101147227 |
| 10426107 | 10069178 | 1.93 | 121.5 | 02 | 2019-07-15 | 2019-11-11 | Dacarbazine | 02 | N | CISPLATIN + FLUOROURACIL | 100900217 |
| 10426962 | 10069180 | 1.64 | 107.8 | null | 2019-11-22 | 2019-12-19 | R CODOX M | 02 | null | CARFILZOMIB | 100865963 |
| 10426982 | 10069181 | null | null | Adjuvant (A) | 2019-05-20 | 2019-05-20 | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | 02 | N | DOXORUBICIN + OLARATUMAB | 100019271 |
| 10427838 | 10069183 | 1.77 | 100 | Curative (C) | 2017-11-08 | 2018-08-22 | null | 02 | N | BRENTUXIMAB | 100875392 |
| 10428617 | 10069185 | null | null | null | 2020-08-01 | 2020-08-01 | null | 02 | null | TRANSPLANT CAR-T CELLS – BREXUCABTAGENE AUTOLEUCEL (KTE-X19) + CYCLOPHOSPHAMIDE + FLUDARABINE | 100631787 |
| 10429313 | 10069188 | 1.73 | 70 | Palliative (P) | 2022-04-03 | 2022-04-24 | CarboPEC-Taxol | 02 | N | PEG INTERFERON | 100516871 |
| 10429360 | 10069189 | 1.59 | 54 | 03 | 2020-03-31 | 2020-04-06 | TRASTUZUMAB DERUXTECAN | 02 | N | TRIAL | 101389522 |
| 10429607 | 10069190 | 1.85 | 89 | Palliative (P) | 2019-02-14 | 2019-02-14 | PENTOSTATIN + RITUXIMAB | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100469914 |
| 10430215 | 10069193 | 1.68 | 99.2 | null | 2019-01-13 | 2019-01-18 | LORLATINIB | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + PERTUZUMAB + TRASTUZUMAB | 100568798 |
| 10430229 | 10069194 | 1.75 | 88 | null | 2020-01-26 | 2020-01-27 | Ipilimumab | 02 | N | CYTARABINE + RITUXIMAB | 100505190 |
| 10430429 | 10069196 | 1.57 | 0 | null | 2021-06-26 | 2021-12-28 | null | 01 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100305062 |
| 10430513 | 10069197 | null | null | Palliative (P) | null | 2019-03-24 | Asciminib | 02 | N | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 101149832 |
| 10430640 | 10069198 | 1.7 | 57.7 | Palliative (P) | null | 2022-04-07 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | INTERFERON ALFA | 100014383 |
| 10431192 | 10069200 | 1.57 | 66.3 | null | 2021-09-15 | 2021-10-04 | null | 02 | null | CISPLATIN + PEMETREXED | 101121873 |
| 10431396 | 10069201 | 1.86 | 50.6 | null | 2019-10-21 | 2019-10-22 | GEMCITABINE + NAB PACLITAXEL | 02 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101036371 |
| 10431408 | 10069202 | 1.86 | 65.2 | 03 | 2022-03-29 | 2022-04-02 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | TOPOTECAN | 100352002 |
| 10431550 | 10069203 | 1.8 | 70 | null | 2019-08-24 | 2019-08-26 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 02 | null | STAMPEDE TRIAL | 101823083 |
| 10431586 | 10069204 | 1.81 | 61 | null | 2019-11-22 | 2019-11-29 | Gemcitabine + Capecitabine | 02 | null | CISPLATIN + FLUOROURACIL | 100908116 |
| 10432730 | 10069207 | 1.81 | 75.5 | null | null | 2019-09-14 | PEMBROLIZUMAB + PEMETREXED | 02 | null | BENDAMUSTINE | 100429081 |
| 10433266 | 10069211 | 1.65 | 56 | Curative (C) | 2021-11-24 | 2021-12-05 | null | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101378340 |
| 10433380 | 10069212 | 0 | 88 | null | 2020-02-17 | 2020-02-17 | MidAC | 02 | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101727333 |
| 10434009 | 10069213 | 1.68 | null | 03 | null | 2018-03-01 | EC | 02 | N | DOCETAXEL + NINTEDANIB | 101751455 |
| 10434938 | 10069215 | 1.63 | 73.1 | null | 2021-04-05 | 2021-04-09 | Folfirinox | 02 | null | STAMPEDE TRIAL | 100844368 |
| 10435119 | 10069217 | 1.54 | 90 | 03 | null | 2020-09-27 | Irinotecan | 02 | N | CARBOPLATIN + DOCETAXEL | 101095777 |
| 10435680 | 10069218 | 1.59 | 106.6 | null | 2019-10-03 | 2019-10-10 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | 02 | N | ETOPOSIDE | 100433817 |
| 10436800 | 10069221 | 1.85 | 0 | null | 2018-03-25 | 2018-03-31 | LENVATINIB | null | null | OLAPARIB | 101460756 |
| 10437192 | 10069223 | 1.51 | 0 | null | 2015-06-26 | 2018-02-14 | CARBO + FLUOROURACIL | 02 | null | ISATUXIMAB + POMALIDOMIDE | 100214368 |
| 10437326 | 10069224 | 1.74 | 45.1 | Palliative (P) | 2020-09-21 | 2020-09-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | BENDAMUSTINE + CYTARABINE + RITUXIMAB | 100374440 |
| 10437947 | 10069225 | 1.69 | 48.25 | null | 2021-11-14 | 2021-11-26 | Pertuzumab | null | null | GEMCARBO | 100152227 |
| 10438141 | 10069226 | 1.66 | 82.2 | Palliative (P) | 2021-06-24 | 2021-07-09 | FCR Oral - Cycle 1 | 02 | N | CYTARABINE | 101511436 |
| 10438175 | 10069227 | 1.69 | 109 | null | 2020-01-03 | 2020-01-31 | CHOP - 21 days | 02 | null | LENVATINIB | 100088426 |